We are live on !
Find out more
Creative Planning Portfolio holdings
AUM
$171B
Turnover
10.62%
1-Year Est. Return
24.68%
This Fund
S&P 500
This Quarter Est. Return
+14.14%
1 Year Est. Return
+24.68%
3 Year Est. Return
+62.17%
5 Year Est. Return
+55.89%
10 Year Est. Return
+171.9%
AUM
$171B
AUM Growth
+$23.7B
(+16%)
Cap. Flow
+$6.93B
Cap. Flow % of AUM
Cap. Flow %
4.05%
Top 10 Holdings %
Top 10 Hldgs %
41.66%
Holding
4,427
New
337
Increased
2,605
Reduced
1,239
Closed
133
Avg Time Held
Equity + Options
4.2
years
Top 10 Avg Time Held
Equity + Options
1.7
years
Top 20 Avg Time Held
Equity + Options
4.3
years
Avg Time Held Equity only
4.3
years
Top 10 Avg Time Held Equity only
1.7
years
Top 20 Avg Time Held Equity only
4.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total Bond Market
BND
|
+$682M |
| 2 |
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
|
+$526M |
| 3 |
Vanguard Short-Term Bond ETF
BSV
|
+$504M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$431M |
| 5 |
State Street SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$239M |
| 2 |
Vanguard Morningstar Large-Cap ETF
VV
|
+$74.4M |
| 3 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$41.1M |
| 4 |
Honeywell
HON
|
+$39.3M |
| 5 |
iShares Core US Aggregate Bond ETF
AGG
|
+$38.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 73.8% |
| 2 | Technology | 9.57% |
| 3 | Financials | 3.79% |
| 4 | Industrials | 2.49% |
| 5 | Healthcare | 2.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2551
Onterris Inc
ONT
$521M
| $1.12M | ﹤0.01% |
55,364
+1,041
| +2% | +$19.4K |
2021 Q1
21 quarters
|
|
2552
NEOS S&P 500 High Income ETF
SPYI
$12.2B
| $1.11M | ﹤0.01% |
20,912
+8,101
| +63% | +$426K |
2024 Q3
7 quarters
|
|
2553
Acadia Pharmaceuticals
ACAD
$3.4B
| $1.11M | ﹤0.01% |
43,862
-3,623
| -8% | -$79.7K |
2024 Q2
8 quarters
|
|
2554
Gabelli Dividend & Income Trust
GDV
$2.45B
| $1.11M | ﹤0.01% |
37,737
-8,277
| -18% | -$239K |
2025 Q1
5 quarters
|
|
2555
Trip.com Group
TCOM
$25B
| $1.11M | ﹤0.01% |
27,824
-158
| -0.6% | -$7.83K |
2019 Q2
28 quarters
|
|
2556
W&T Offshore
WTI
$632M
| $1.11M | ﹤0.01% |
351,485
+160,942
| +84% | +$597K |
2018 Q4
30 quarters
|
|
2557
Neogen
NEOG
$2.66B
| $1.11M | ﹤0.01% |
123,082
-15,477
| -11% | -$142K |
2015 Q3
43 quarters
|
|
2558
CCC Intelligent Solutions
CCC
$4.52B
| $1.11M | ﹤0.01% |
214,311
-94,671
| -31% | -$468K |
2025 Q2
4 quarters
|
|
2559
Amplify Blockchain Technology ETF
BLOK
$925M
| $1.11M | ﹤0.01% |
17,648
+3,591
| +26% | +$222K |
2021 Q1
21 quarters
|
|
2560
DELISTED
Select Medical
SEM
| $1.1M | ﹤0.01% |
66,929
+8,909
| +15% | +$147K |
2024 Q1
9 quarters
|
|
2561
MarineMax
HZO
$1.16B
| $1.1M | ﹤0.01% |
30,150
+2,040
| +7% | +$65.5K |
2026 Q1
1 quarter
|
|
2562
Republic Bancorp
RBCAA
$1.8B
| $1.1M | ﹤0.01% |
12,199
+2,179
| +22% | +$173K |
2024 Q3
7 quarters
|
|
2563
Enerpac Tool Group
EPAC
$1.83B
| $1.1M | ﹤0.01% |
30,637
+23,454
| +327% | +$823K |
2026 Q1
1 quarter
|
|
2564
United Natural Foods
UNFI
$2.83B
| $1.1M | ﹤0.01% |
24,054
+4,109
| +21% | +$204K |
2024 Q2
8 quarters
|
|
2565
RXO
RXO
$4.74B
| $1.1M | ﹤0.01% |
39,771
+10,566
| +36% | +$233K |
2024 Q3
7 quarters
|
|
2566
Green Dot
GDOT
$704M
| $1.1M | ﹤0.01% |
81,206
-44,584
| -35% | -$558K |
2025 Q2
4 quarters
|
|
2567
Red Violet
RDVT
$1.3B
| $1.09M | ﹤0.01% |
17,160
+4,373
| +34% | +$207K |
2025 Q2
4 quarters
|
|
2568
Aclaris Therapeutics
ACRS
$552M
| $1.09M | ﹤0.01% |
206,647
+54,559
| +36% | +$243K |
2025 Q4
2 quarters
|
|
2569
UWM Holdings
UWMC
$500M
| $1.09M | ﹤0.01% |
476,961
+256,810
| +117% | +$798K |
2023 Q4
10 quarters
|
|
2570
Liberty Live Group Series A
LLYVA
$8.87B
| $1.09M | ﹤0.01% |
10,784
-700
| -6% | -$66.3K |
2024 Q4
6 quarters
|
|
2571
Independent Bank Corp
IBCP
$821M
| $1.09M | ﹤0.01% |
30,247
+4,514
| +18% | +$154K |
2019 Q3
27 quarters
|
|
2572
Phreesia
PHR
$788M
| $1.09M | ﹤0.01% |
105,955
+10,728
| +11% | +$100K |
2026 Q1
1 quarter
|
|
2573
Penumbra
PEN
$12.8B
| $1.09M | ﹤0.01% |
3,450
-640
| -16% | -$207K |
2023 Q1
13 quarters
|
|
2574
Provident Financial Services
PFS
$3.03B
| $1.09M | ﹤0.01% |
46,038
+427
| +0.9% | +$9.6K |
2023 Q3
11 quarters
|
|
2575
ProShares Ultra Semiconductors
USD
$2.27B
| $1.09M | ﹤0.01% |
10,411
+972
| +10% | +$84.6K |
2026 Q1
1 quarter
|
|
Similar funds
Creative Planning's Q2 2026 Portfolio in Review
As of Q2 2026, Creative Planning held 4,427 positions worth $171B, up 16% from $147B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Creative Planning deployed $6.93B of net new capital in Q2 2026, opening 337 new positions and adding to 2,605 existing holdings. Its largest new stake was Honeywell Aerospace: 169,880 shares worth $37.6M.
By sector, the portfolio is most concentrated in Miscellaneous at 74% of assets, down from 76% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Vanguard FTSE Developed Markets ETF, an estimated $239M trimmed.
- Creative Planning's largest Q2 2026 buy was Honeywell Aerospace: 169,880 shares worth $37.6M.
- Creative Planning added most to Vanguard Total Bond Market in Q2 2026, an estimated $682M increase.
- Creative Planning's biggest Q2 2026 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $239M.
- Creative Planning fully exited Hologic in Q2 2026, selling an estimated $8.29M.
- Creative Planning's ten largest holdings make up 42% of its $171B portfolio in Q2 2026.
- Creative Planning opened 337 new positions and closed 133 in Q2 2026.
- Creative Planning's portfolio value rose 16% quarter-over-quarter to $171B.
Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.